ALZ-50 is a monoclonal antibody that recognizes a protein of apparent molecular mass 68 kilodaltons (A68). The protein is present in the brains of patients with Alzheimer disease but is not detectable in normal adult brain tissue. We now report that ALZ-50-reactive neurons are found in normal fetal and neonatal human brain and in brain tissue from neonatal individuals with Down syndrome. Reactive neurons decrease sharply in number after age 2 and reappear in older individuals with Down syndrome and in patients with Alzheimer disease.
Alzheimer disease is a progressive neurodegenerative syndrome affecting 7% of the population over 65 years of age (1) . Recently, we have used the monoclonal antibody ALZ-50 to identify a 68-kDa protein, A68, that accumulates in neuronal elements in the brains of AD patients (2) . A68 is not detectable in age-matched controls. The apparent absence of A68 from normal brain tissue raises the question of whether it is a foreign protein or a reexpressed human protein or protein epitope. To address this issue we have studied the expression of A68 throughout the life span in brains from neurologically normal individuals and brains from individuals with Down syndrome. Abundant evidence supports the suggestion that virtually all individuals with Down syndrome will develop Alzheimer disease ifthey live until middle age (3, 4) . Thus, by using Down syndrome tissue, it is possible to study the development of A68 in Alzheimer disease. We report here that ALZ-50 recognizes a developmentally regulated antigen present in individual neurons in fetal and neonatal tissue in both Down syndrome and control tissue. A68 reactivity is virtually absent by 6 years of age, but it reappears and becomes widespread as the pathology of Alzheimer disease develops.
MATERIALS AND METHODS
Formalin-fixed cortical sections from Down syndrome and control brains were examined by using ALZ-50 immunocytochemistry (2) . The cases studied are listed in Table 1 . In all cases, blocks of midtemporal gyrus were cut on a Vibratome. In a limited number of cases, other brain regions were also examined. Free-floating 50-,m sections were incubated in 3% (vol/vol) hydrogen peroxide/0.2% Triton X-100 for 30 min at room temperature. After washing with Tris-buffered saline (TBS; 10 mM Tris.HCl/140 mM NaCl, pH 7.4), sections were incubated for 1 hr at room temperature in 5% nonfat dried milk in TBS to prevent nonspecific antibody binding. Sections were transferred to either ALZ-50 culture supernatant diluted 1:5 with 5% milk in TBS or to hybridoma medium similarly diluted (no-antibody blank), and incubated overnight with gentle agitation at 4°C. After five washes, each for 5 min in TBS, sections were incubated with peroxidaselabeled goat anti-mouse IgG (heavy and light chain specific, from Boehringer Mannheim), diluted 1:500 in TBS/5% milk for 2 hr at room temperature. After a further five washes in TBS, bound peroxidase was visualized with diaminobenzidine, as previously described (2) . The amount of immunoreactivity was quantitated by counting the number of ALZ-50-positive neurons per tissue section.
RESULTS
Staining of neurons in the developing human brain by ALZ-50 was discovered on examination of temporal cortex from three infants with Down syndrome, aged 5, 9, and 11 months at death. In an attempt to define the age at which this phenomenon first became apparent, samples from six fetal brains, Abbreviation: MAP-2, microtubule-associated protein 2.
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three Down syndrome and three normals, 18-24 weeks old, were examined. Careful examination did not reveal a single positive cell. Multiple sections of several brain regions were examined, and they were processed along with sections from infants, which always demonstrated neuronal staining. A seventh fetus, a 16-week fetus with Down syndrome, did contain many ALZ-50-positive neurons in the cerebral cortex. The reason for this discrepancy is unclear. It does not appear to be due to differences in tissue handling or fixation, as we have demonstrated that ALZ-50 reactivity is preserved despite storage of brain tissues in Formalin for over 10 years. The mother of this fetus belongs to a population at high risk for HIV infection.
In 6 out of 7 cases, ALZ-50-positive cells are not found prior to 24 weeks; these cells appear to arise closer to birth.
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Proc. Nat!. Acad. Sci. USA 85 (1988) 6203 Tissue sections from stillborn infants, one estimated to be 34-36 weeks, the other full term, were clearly positive and demonstrated neuronal staining very similar to that seen in the six older infants examined. The morphology of ALZ-50 staining was highly distinctive in that the staining was restricted to discrete, relatively diffusely distributed neurons ( Fig. 1 a and b) . These neurons could be found in layers 2 through 6 of the cortex but were more often deep than close to the pial surface. The majority of stained neurons were found in white matter rather than in grey. Representative examples of the distribution of neuronal staining in a 5-month-old normal and a Down syndrome infant of the same age are provided in Fig. 2 . A similar pattern of neuronal staining was observed in all cortical regions examined (midfrontal, inferior parietal, temporal, and occipital). Very few (Fig. 1 c and d) . The processes could be followed until they exited the tissue section. They often exhibited varicosities for the length of the process (Fig. 1d) . In samples from older children, ALZ-SO reactivity was essentially absent at ages over 2. The number of neurons stained per tissue section falls to the level found in studies of more than 20 normal adults (less than 1 neuron per cm2). This is true for samples from both normals and individuals with Down syndrome.
The earliest reexpression of ALZ-50 immunoreactivity we have observed has been in samples from a 29-year-old Down syndrome patient, though it remained absent from adult control tissue. Immunoreactive neurons with extensive processes could be seen in layers 5 and 6 (Fig. 3a) . These neurons resembled interneurons seen in the tissue sections from infants, though staining of some pyramidal neurons was occasionally seen. Fibers with pitted varicosities could be seen coursing through cortical gray matter and occasionally through white matter. To examine the relationship between the immunostained structures and the appearance of neurofibrillary pathology, the tissue sections were double-stained with thioflavine S (a marker of neurofibrillary pathology) and ALZ-50 plus rhodamine-conjugated secondary antibody. The large varicosities stained with ALZ-50 were found to correspond with thioflavine S-positive neuritic plaques which were occasionally present in the tissue. No thioflavine S-positive neuronal cell bodies were seen in the tissue.
The immunostaining of brain tissue from a 40-year-old Down syndrome patient revealed staining of occasional plaques, many neurons, and moderately abundant neurites coursing throughout the neuropil (Fig. 3 b and c) . Unlike in the tissue from the 29-year-old Down syndrome patient, stained neurons could be found throughout all layers of the cortex. Moreover, the type of neuron stained shifted to include many pyramidal neurons. The extent of the stained axonal and dendritic processes emanating from the cell bodies appeared to be decreased, and the processes often extended only [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] A&m from the cell body. Double-staining with thioflavine S and ALZ-50 revealed a concordance for staining of neuritic plaques as seen in the tissue from the 29-year-old Down syndrome patient. Thioflavine S-positive/ALZ-50-positive neurons were present as well as thioflavine S-negative/ALZ-50-positive neurons. Few of the ALZ-50-positive neurites were stained by thioflavine S. The older Down syndrome tissue, ages 52, 54, and 62, exhibited extensive staining of neurons, neuritic plaques, and neurites (Fig. 3d) . The staining appeared very similar to that seen in Alzheimer disease tissue (Fig. 3e) . Double-staining with thioflavine S and ALZ-50 revealed results similar to those seen in the tissue from the 40-year-old Down syndrome patient.
An essential question is whether the immunoreactive species is the same in Down syndrome and Alzheimer disease. To address this question, immunoreactive material from the brain of a 62-year-old individual with Down syndrome was purified by gel chromatography on a Sepharose 6B column and then subjected to electrophoretic blotting or enzyme-linked immunoassay (ELISA) analysis, as was described previously (2) . The elution profile ofDown syndrome tissue was identical to that of Alzheimer disease tissue, yielding a large immunoreactive peak only at the void volume. Electrophoretic blot analysis of the void volume fraction revealed immunoreactivity at 68 kDa, indicating that the immunoreactive species is A68 (Fig. 4) . Tissue from Down syndrome individuals aged 5 months and 7 years was also examined by gel chromatography. Attempts to use electrophoretic blot analysis were unsuccessful, because of the limited amount of immunoreactivity present. The amount ofimmunoreactivity present at the void volume in all samples correlated with the amount of reactivity seen by immunocytochemistry. Void volume fractions were serially diluted and examined by ELISA (2) . The relative amounts of antigen in the void volume fractions from the 62-year-, 7-year-, and 5-month-old samples were, respectively, 100, 0.080, and 1.9. Thus, the 62-year-old Down syndrome patient had 52 times as much reactivity as the 5-month-old patient and 1200 times as much reactivity as the 7-year-old patient. Frozen tissue was not available from other infant brains. The presence of antigen from the young Down syndrome specimens at the void volume combined with the correlation of ELISA quantitation with immunocytochemical quantitation indicates that the reactive species in the specimens of young as well as in the old Down syndrome specimens is A68. However, proving The distribution and morphology of the neurons stained by ALZ-50 is very strikingly similar to the distribution and morphology of subplate and marginal zone neurons (12, 13) . These are neurons that undergo their final round of cell division early in brain development in both primates and cats (13, 14) . Recent work has shown that neuron-specific markers such as MAP-2 and neuropeptides are present in these cells and that they receive synaptic contacts (15 dergo what has been termed programmed cell death, and it is tempting to speculate that ALZ-50 marks a population ofcells that will die in the developing human brain, as it appears to do in older individuals with Down syndrome and Alzheimer disease (16, 17) .
